Almac and DSM Pharmaceutical Products will partner their biocatalysis capabilities for the manufacturing of APIs. Almac said its expertise in rapid enzyme identification, scale-up and implementation into early phase projects complements DSM’s experience and track record of over 30 commercial manufacturing bioprocesses run on a multi-ton scale.
Pharmaceutical Business Review
Wednesday 10 October 2012
Almac and DSM to collaborate in biocatalysis
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment